Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Kezar Life Sciences Inc (NQ: KZR ) 0.6301 -0.0129 (-2.01%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 19, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Kezar Life Sciences Inc < Previous 1 2 3 4 Next > KZR Stock Earnings: Kezar Life Sciences Beats EPS for Q1 2024 May 09, 2024 KZR stock results show that Kezar Life Sciences beat analyst estimates for earnings per share the first quarter of 2024. Via InvestorPlace From Pennies to Fortunes: 3 Stocks Set to Make Millionaires March 27, 2024 Discover how these stocks to make millionaires are leading in the gold, biotechnology, and application software industries. Via InvestorPlace Diamonds in the Dust: 3 Penny Stocks Set to Soar 500% by 2026 March 16, 2024 Learn how these penny stocks may yield a 5X return with their lead in application software and biotechnology. Via InvestorPlace KZR Stock Earnings: Kezar Life Sciences Misses EPS for Q4 2023 March 14, 2024 KZR stock results show that Kezar Life Sciences missed analyst estimates for earnings per share the fourth quarter of 2023. Via InvestorPlace Week In Review: Mabwell Sells Ex-China Rights To Rare Disease Therapy In $412 Million Deal March 02, 2024 Mabwell, a Shanghai-San Diego biotech, sold ex-China rights for 9MW3011 to Disc Medicine of Watertown, MA in a deal worth up to $412 million. Meanwhile, AstraZeneca has returned most of the global... Via Talk Markets Analyst Expectations for Kezar Life Sciences's Future November 27, 2023 Via Benzinga Kezar Life Sciences: Q1 Earnings Insights May 11, 2023 Via Benzinga 3 Top Penny Stocks for 5,000% Upside in 2024 and Beyond February 25, 2024 When you want to light your afterburners, these ideas will do the trick. Via InvestorPlace 3 Penny Stocks Poised for an Unbelievable 1,000% Jump February 02, 2024 Discover penny stocks with the potential for a 1,000% leap: strategic growth, debt-free stability and pharmaceutical innovation await. Via InvestorPlace As Oversupply Deflates Lithium Bubble, IPO Market Keeps In High Spirits January 08, 2024 Lithium market facing persistent turmoil as spot prices decline for more than a year. But asset management firm Janus Henderson sees a silver lining. Via Benzinga Topics Initial Public Offering Exposures Securities Market Bull Run Bonanza: Top 3 Penny Stocks Primed for Explosive Growth December 18, 2023 Are you looking for the next bull run bonanza? Here are the top three penny stocks primed for explosive growth. Via InvestorPlace Week In Review: Everest Acquires Novel Autoimmune Therapy In $132 Million Agreement September 23, 2023 Shanghai Everest Medicines acquired China/Asian rights to a novel therapy for autoimmune diseases from Kezar Life Sciences of South San Francisco in a deal worth $132.5 million. The company will make... Via Talk Markets Benzinga's Top Ratings Upgrades, Downgrades For October 5, 2023 October 05, 2023 Via Benzinga Why Murphy Canyon Acquisition Shares Are Trading Higher By Around 32%; Here Are 20 Stocks Moving Premarket September 21, 2023 Gainers Near Intelligence, Inc. (NASDAQ: NIR) shares rose 34.1% to $0.2801 in pre-market trading after falling 42% on Wednesday. Near Intelligence recently named its General Counsel, Jay Angelo, to... Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session August 22, 2023 Via Benzinga Top 5 Health Care Stocks That Could Blast Off This Month August 21, 2023 The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. Via Benzinga 12 Health Care Stocks Moving In Tuesday's After-Market Session August 15, 2023 Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session August 11, 2023 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For August 11, 2023 August 11, 2023 Via Benzinga Why Maxeon Solar Technologies Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Friday's Mid-Day Session August 11, 2023 Gainers Amyris, Inc. (NASDAQ: AMRS) shares jumped 179.1% to $0.1839. Amyris shares dipped over 80% on Thursday after the company announced it filed for Chapter 11 bankruptcy. Via Benzinga Topics Bankruptcy Exposures Financial Legal Stocks That Hit 52-Week Lows On Thursday July 27, 2023 During Thursday, 56 stocks hit new 52-week lows. Via Benzinga Stocks That Hit 52-Week Lows On Tuesday July 25, 2023 On Tuesday, 56 companies set new 52-week lows. Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session June 08, 2023 Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session March 16, 2023 Via Benzinga Stocks That Hit 52-Week Lows On Monday April 03, 2023 On Monday, 76 companies set new 52-week lows. Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For March 16, 2023 March 16, 2023 Via Benzinga 12 Health Care Stocks Moving In Wednesday's After-Market Session March 01, 2023 Via Benzinga Why Kezar Life Sciences Shares Are Volatile After Hours October 03, 2022 Kezar Life Sciences Inc (NASDAQ: KZR) shares are trading higher in Monday's after-hours session after the company announced that it has received clearance of its Investigational New Drug (IND)... Via Benzinga Kezar Life Sciences Stock Shows Rising Market Leadership: Earns 81 RS Rating July 08, 2022 The Relative Strength (RS) Rating for Kezar Life Sciences stock jumped into a new percentile Friday, with a rise from 78 to 81. Via Investor's Business Daily The Week In Charts: How To Make Money While Waiting For Core Trend Trades July 02, 2022 The real money is in the longer-term core trend trades. However, sometimes those opportunities can be few and far between. This is especially true in a bear market. Via Talk Markets < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.